Zobrazeno 1 - 10
of 78
pro vyhledávání: '"F. Asrari"'
Autor:
F. Asrari, Raul Gonzalez, R. Voong, Todd McNutt, Christina Tsien, Jennifer Vogel, Amol Narang, Sara R. Alcorn, Matthew M. Ladra, Jean L. Wright, Ana P. Kiess, J. Wieworka, S. Han-Oh, Amanda J. Walker, Lan Lin, Russel Hales, Marikki Laiho, Roberta Anderson, Danny Y. Song, Akila N. Viswanathan, Victoria Croog, Phuoc T. Tran, Kristin J. Redmond, Harry Quon, Brandi R. Page, Stephen Greco, Jeffrey J Meyer, Lawrence Kleinberg, Curtiland Deville
Publikováno v:
Advances in Radiation Oncology. 5:666-672
Autor:
F. Asrari, Amanda L. Blackford, Mehran Habibi, Zohaib Akhtar, Danijela Jelovac, Vered Stearns, Paul Cartwright, Catherine Klein, Vishnu Prasath
Publikováno v:
Breast Cancer Research and Treatment. 182:623-629
A delay in breast cancer treatment is associated with inferior survival outcomes; however, no clear guidelines exist defining the appropriate time frame from diagnosis to definitive treatment of breast cancer. A multidisciplinary approach for breast
Autor:
A.W. LaVigne, T. Dyson, T.A. Jamerson, N. Kim, F. Asrari, J.L. Wright, C.U. Aguh, S.R. Alcorn
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 114:S72
Autor:
Amanda L. Blackford, F. Asrari, Youngjee Choi, Walid El Ayass, Patricia Njoku, Melissa Camp, Carol D. Riley, Nancy Mayonado, Sharon White, Nelli Zafman, Antonio C. Wolff, Elissa Thorner, Aishwarya Shukla, Jean L. Wright, Katie Papathakis, Claire F. Snyder, Katherine Clegg Smith, Kimberly S. Peairs
Publikováno v:
Breast Cancer Research and Treatment. 179:415-424
Survivorship care plans (SCPs) provide key information about cancer treatment history and follow-up recommendations. We describe the completeness of breast cancer SCPs and evaluate guideline concordance of follow-up recommendations. We analyzed 149 b
Autor:
Avani D. Rao, Melissa Camp, F. Asrari, Chen Hu, Jean L. Wright, Sara R. Alcorn, Arti Parekh, Wei Fu, Colette J. Shen
Publikováno v:
Breast Cancer Research and Treatment. 172:201-208
Many eligible women with invasive breast cancer do not receive recommended adjuvant radiation (RT), despite its role in local control and overall survival. We examined trends in RT use over 10 years, and the impact of sociodemographic factors on the
Publikováno v:
Cancer Research. 78:P4-10
This abstract was withdrawn by the authors.
Autor:
F. Asrari, Melissa Camp, Arti Parekh, Daniel J. Zabranksy, Richard C. Zellars, Avani D. Dholakia, Mehran Habibi, Jean L. Wright
Publikováno v:
Advances in Radiation Oncology, Vol 3, Iss 1, Pp 8-15 (2018)
Advances in Radiation Oncology
Advances in Radiation Oncology
Purpose The associations among radiation fractionation, body mass index (BMI), and acute skin toxicity with adjuvant radiation for breast cancer is of increasing interest. This study evaluated the rate of grade ≥2 dermatitis and moist desquamation
Autor:
S.A. Dudley, Todd McNutt, Sara R. Alcorn, F. Asrari, V.J. Croog, Jean L. Wright, A.V. Reddy, J. Hirshberg, S.F. Stinson, Amanda J. Walker
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 108:e74
Autor:
Lindsey Sloan, Sara R. Alcorn, Victoria Croog, Todd McNutt, Susan F. Stinson, F. Asrari, Jean L. Wright, Bethlehem Floreza, Arcelia Weaver
Publikováno v:
Rep Pract Oncol Radiother
PURPOSE: Adjacent tissues-in-beam (TIB) may receive substantial incidental doses within standard tangent fields during hypofractioned whole breast irradiation (HF-WBI). To characterize the impact of dose to TIB, we analyzed dosimetric parameters of T
Autor:
F. Asrari, C. Yu, Stephen Greco, T.L. DeWeese, Curtiland Deville, R. Kumar, Phuoc T. Tran, M. Han, Michael A. Gorin, Danny Y. Song, Matthew P. Deek, H. Hasan, S. Di Pasquale, Ryan Phillips, J. Huang
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 105:E302-E303